Research has examined whether GLP-1 receptor agonists like Ozempic can help treat obesity and reduce some of the cardiovascular risks associated with obesity since GLP-1 receptor agonists such as Ozempic have caused weight loss in people with type 2 diabetes
In the first weeks it calls for symptom assessment and a TSH recheck if weight loss has been significant, then a review around the two to three month mark where levothyroxine is adjusted if TSH has drifted, followed by periodic panels during maintenance
Sources: USA Today, JAMA, JAMA Ophthalmology, FDA, Reuters, KFF, MDL Update, Drugwatch, About Lawsuits
10.1016/j.ccr.2012.10.024 Cancer Cell 12 JakovcevskiM.RuanH.ShenE
Int J food Prop 20:769781
It also includes people who drink excessive amounts of alcohol and those who take certain other drugs, such as topiramate (Topamax)